QLT closes Aczone deal with Allergan - Pharmaceutical industry …

Jul 20, 2008 · Canada's QLT says that its wholly-owned US subsidiary has completed the sale of its Aczone (dapsone) Gel 5% product, a topical treatment for acne vulgaris, to USA-based …

5%
OFF

QLT Closes Aczone Deal With Allergan - Pharmaceutical Industry …

2 weeks from now

Jul 20, 2008 · Canada's QLT says that its wholly-owned US subsidiary has completed the sale of its Aczone (dapsone) Gel 5% product, a topical treatment for acne vulgaris, to USA-based …

thepharmaletter.com

$150
OFF

Allergan Completes Purchase Of Acne Treatment Drug

2 weeks from now

Aug 5, 2008 · Allergan paid $150 million to purchase the brand from QLT USA, which is based in Fort Collins, Colo., and is an arm of QLT, based in Vancouver, Canada. Allergan plans to …

dermatologytimes.com

$150
OFF

Allergan To Buy QLT's Acne Gel For $150 Mln | Reuters

2 weeks from now

Jun 9, 2008 · Allergan Inc <AGN.N>, maker of the Botox anti-wrinkle treatment, will buy QLT Inc's <QLT.TO> Aczone Gel for acne for $150 million, the companies said on Monday.

reuters.com

5%
OFF

Allergan Closes Purchase Of Aczone Gel For $150 Million

2 weeks from now

Allergan Closes Purchase of Aczone Gel for $150 Million July 15, 2008 Allergan’s wholly owned subsidiary, Allergan Sales, LLC, announced the completion of acquisition of Aczone Gel 5% …

fdanews.com

$150
OFF

QLT Completes Divestment Of Aczone To Allergan For USD$150 …

2 weeks from now

Jul 14, 2008 · QLT Completes Divestment of Aczone to Allergan for USD$150 Million. Vancouver, BC, July 14, 2008--QLT Inc. today announced that QLT USA, Inc., its wholly-owned …

bctechnology.com

$150
OFF

QLT Offloads Acne Drug In US$150 Million Deal As Vancouver …

2 weeks from now

Jul 15, 2008 · QLT Inc. (TSX:QLT; Nasdaq:QLTI) has sold its Aczone topical acne treatment to a subsidiary of California-based Allergan Inc. for US$150 million. The deal is part of the …

biv.com

$150
OFF

Allergan Acquires QLT Acne Treatment - Pharmaceutical Industry …

2 weeks from now

Jun 15, 2008 · US drugmaker Allergan has acquired the rights to Aczone (dapsone) topical gel, for the treatment of acne, from the US arm of Canada's QLT for $150.0 million. Allergan will …

thepharmaletter.com

$150
OFF

Allergan Purchases Aczone From QLT | Drug Store News

2 weeks from now

Allergan paid about $150 million for all assets relating to the Aczone product. Allergan expects to launch the drug in the fourth quarter of 2008 in the U.S. and Canada. Related Topics

drugstorenews.com

$150
OFF

QLT Sells Acne Treatment Product To Allergan - The ... - The Globe …

2 weeks from now

Jun 9, 2008 · Struggling Vancouver drug-maker QLT Inc. has struck a long-awaited deal to sell its Aczone acne treatment for $150-million (U.S.), three months after U.S. regulators waived an …

theglobeandmail.com

$150
OFF

Allergan Acquires QLT Acne Treatment - Pharmaceutical Industry …

2 weeks from now

US drugmaker Allergan has acquired the rights to Aczone (dapsone) topical gel, for the treatment of acne, from the US arm of Canada's QLT for $150.0 million. Allergan will receive all assets …

thepharmaletter.com

$100
OFF

QLT Stock Rockets As Acne Drug Is Cleared For Takeoff

2 weeks from now

Mar 18, 2008 · QLT says the acne medication has the potential to earn around $100 million a year. Analysts say that even if a buyer can't be found QLT can go ahead and launch the new …

fiercebiotech.com

$150
OFF

Allergan To Buy QLT’s Acne Gel For $150 Million

2 weeks from now

Jun 9, 2008 · NEW YORK (Reuters) – Allergan Inc (AGN.N: Quote, Profile, Research), maker of the Botox anti-wrinkle treatment, will buy QLT Inc’s (QLT.TO: Quote, Profile, Research) …

plasticsurgerypractice.com

$150
OFF

Allergan Inc. To Buy QLT Inc.'s Acne Gel For $150 Million

2 weeks from now

Jun 9, 2008 · Allergan Inc. to Buy QLT Inc.'s Acne Gel for $150 Million - read this article along with other careers information, tips and advice on BioSpace ... Our research and development …

biospace.com

$150
OFF

QLT Sells Acne Gel Product Aczone For $150M To Allergan

2 weeks from now

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, …

bioworld.com

FAQs about QLT closes Aczone deal with Allergan - Pharmaceutical industry … Coupon?

How much cash will Allergan receive at closing?

Per deal terms, Allergan will receive $550 million upfront in cash at deal closing. The products all come from Allergan’s medical dermatology unit: Aczone, Tazorac, Azelez, Cordran Tape and Seysara, which is currently under review by the Food and Drug Administration. ...

What happened to Allergan in the first half of 2018?

In the first half of 2018, Allergan said it paid down $4.7 billion. Aczone and Tazorac both recently lost patent exclusivity and have seen their sales suffer. According to company filings, Aczone sales dropped 55% over the first six months of 2018 compared to the same period last year. Tazorac sales fell 56%, from $36 million to $16 million. ...

Will Almirall buy Allergan?

Almirall said Friday it will buy five dermatology drugs from Allergan, furthering the Spanish pharma’s plans to expand its U.S. presence. Per deal terms, Allergan will receive $550 million upfront in cash at deal closing. ...